| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.16 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |